Sun Pharmaceutical Industries Ltd.
-31.35 (-1.84%) Sun Pharmaceutical Industries reports 6% rise in Q2 consolidated net profit
Date: 01-11-2023Sun Pharmaceutical Industries has reported results for second quarter ended September 30, 2023 (Q2FY24).
The company has reported 26.74% fall in its net profit at Rs 888.63 crore for Q2FY24 as compared to Rs 1213.01 crore for the same quarter in the previous year. Total income of the company decreased by 2.33% at Rs 5202.75 crore for Q2FY24 as compared Rs 5327.00 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 5.73% rise in its net profit at Rs 2385.10 crore for the quarter under review as compared to Rs 2255.90 crore for the same quarter in the previous year. Total income of the company increased by 13.12% at Rs 12486.02 crore for Q2FY24 as compared Rs 11037.50 crore for the corresponding quarter previous year.